H.C. Wainwright Reiterates Buy Rating on Actuate Therapeutics (ACTU)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| ACTUATE (NASDAQ: ACTU) | Delayed: 0.68 -0.04 (5.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.72 | 52 Week High | $6.07 | |||
| Open | $0.68 | 52 Week Low | $3.89 | |||
| Day High | $0.72 | P/E | 4.53 | |||
| Day Low | $0.62 | EPS | $0.15 | |||
| Volume | 324,365 | |||||
